DKCRUSH-V: Left Main, Not Just Another Bifurcation

Cardiac Artery Bypass Graft Surgery has been shown more effective than percutaneous coronary intervention (basically because it renders lower revascularization rate) in patients with severe left main  bifurcation lesions receiving 1st generation drug eluting stents. This is why the 2014 American guidelines recommend CABG for most patients.

DKCRUSH-V: El tronco de la coronaria izquierda no es una bifurcación más

But the EXCEL and the NOBLE trials brought back hope to interventional cardiologists and reinstalled the question about what technique to use on bifurcations, since approximately 80% of lesions involve the distal segment.


Read also: DKCRUSH-V: What Is Simple Is Not Always Best for the Left Main Coronary Artery”.


Both the EXCEL and the NOBLE favored provisional stenting to treat left main bifurcations. 

 

The planned DK crush 2-stent technique has improved results in other bifurcations. Specifically, in left main bifurcations, this technique has been shown superior to culotte stenting. However, it had never been tested against provisional stenting.

 

482 patients from 26 centers and 5 countries with left main bifurcation lesions (Medina 1,1,1 or 0,1,1) were randomized to provisional stenting (n=242) vs. DK crush technique (n=240). Primary end point was a composite of cardiac death, vessel related infarction or clinically driven revascularization. There was routine angiographic follow up at 13 months.


Read also: Ischemic and Bleeding Risk After Primary Angioplasty”.


Primary end point at one year occurred in 26 patients undergoing provisional stenting (10.7%) and in 12 patients (5%) of patients undergoing DK crush (HR: 0.42, CI 95%: 0.21 to 0.85; p=0.02).

 

In addition, DK crush resulted in lower rates of target vessel MI (2.9% vs. 0.4%; p=0.03) and definite/probable thrombosis (3.3% vs. 0.4%; p=0.02).

 

Clinically driven revascularization (7.9% vs. 3.8%; p=0.06) and angiographic restenosis (14.6% vs. 7.1%; p=0.10) were also lower with the DK crush technique, compared to provisional stenting.


Read also: Angioplasty Complexity May Define the Duration of Dual Antiplatelet Therapy”.


Cardiac mortality was similar in both groups.

 

Conclusion

Distal left main bifurcation using planned DK crush 2-stent technique resulted in a lower rate of the composite of death, target vessel infarction and target vessel revascularization, vs. the traditional provisional stenting.

 

Editorial Comment

The group randomized to provisional stenting required a second bailout stent 47% of the time. This percentage is relatively high, and speaks of bifurcation lesions.

 

DK crush V is the first study to assess clinical and angiographic results of left main bifurcations with this technique vs. provisional stenting. Prior to this study, the DK crush III had been tested against culotte stenting.

 

Possible explanations for the difference between these outcomes and those of the rest of studies that had deemed provisional stenting superior, could be that left main caliber is always bigger, bifurcation angle is in general more open and trifurcations are rare at left main level.

 

Original title: Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions. DKCRUSH-V Randomized Trial.

Reference: Shao-Liang Chen et al. J Am Coll Cardiol 2017, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been shown to reduce the risk of cardiovascular...

AHA 2025 | TUXEDO-2: Post-PCI Antiplatelet Management in Diabetic Patients with Multivessel Disease — Ticagrelor or Prasugrel?

Choosing the optimal P2Y12 inhibitor for diabetic patients with multivessel coronary artery disease undergoing percutaneous coronary intervention (PCI) remains a major clinical challenge. These...

AHA 2025 | DECAF: Coffee Consumption vs. Abstinence in Patients with Atrial Fibrillation: Recurrence or Myth?

The link between coffee consumption and arrhythmia has been met with contradicting recommendations. It is widely believed that caffeine could trigger atrial fibrillation (AF)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...

AHA 2025 | CLOSURE-AF: Left Atrial Appendage Occlusion (LAAO) vs. Medical Therapy in Atrial Fibrillation with High Stroke and Bleeding Risk

Atrial fibrillation (AF) is a complex condition in which patients often present with multiple comorbidities, including high bleeding risk. Percutaneous left atrial appendage occlusion...